Company Filing History:
2 out of 4 
2 out of 2 Years Active: 2019-2021
Title: The Innovative Contributions of Inventor María Clara Póvoa Cabral
Introduction
María Clara Póvoa Cabral is a notable inventor based in A Coruña, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of live attenuated vaccines. With a total of two patents to his name, his work has the potential to impact public health positively.
Latest Patents
His latest patents focus on a method for the production of live attenuated bacterial strains that are suitable as vaccine candidates. The process involves providing a bacterial strain capable of expressing glutamate racemase and possibly D-amino acid transaminase, along with a peptidoglycan cell wall. The invention includes steps for inactivating the genes encoding for the glutamate racemase enzyme and, if necessary, the genes for the enzyme D-amino acid transaminase. This inactivation results in a bacterial strain that is auxotrophic for D-glutamate, making it a promising candidate for vaccine development.
Career Highlights
Throughout his career, María Clara has worked with various organizations, including the Servicio Galego De Saúde (Sergas) and Fundación Profesor Novoa Santos. His experience in these institutions has allowed him to collaborate on innovative projects that advance the field of medical research.
Collaborations
He has collaborated with notable colleagues such as Germán Bou Arévalo and Astrid Pérez Gómez. These partnerships have contributed to the successful development of his patents and have fostered a collaborative environment for innovation.
Conclusion
María Clara Póvoa Cabral's work in the field of live attenuated vaccines showcases his dedication to advancing medical science. His innovative methods and collaborations highlight the importance of teamwork in achieving significant breakthroughs.